Cooling-Triggered Release of Celecoxib from Implantable Alginate-Soluplus Composite Devices

冷却触发式塞来昔布从可植入的藻酸盐-Soluplus复合装置中释放

阅读:1

Abstract

Currently, on-demand treatment of pain (both chronic and acute) is primarily achieved using opioids that are delivered systemically. Unfortunately, these drugs are highly addictive; over 5 people per hour die from opioid abuse in the US alone. A safer, nonsystemic mechanism for pain relief is therefore needed. Nonsteroidal anti-inflammatory drugs (NSAIDs) have been explored for this purpose; they are nonaddictive, provide excellent pain relief, and can be delivered locally to minimize dosage and systemic side effects. However, an on-demand release method is needed to make local delivery of these drugs a viable, convenient replacement for opioids; external stimulus-triggered release from an implantable depot is one approach. Stimuli such as heat, light, ultrasound, and RF electromagnetic radiation have been used to trigger release of various drugs from implantable drug depots; however, these require energy input and complex apparatus and are thus not comparable to the ease of oral administration. We propose localized cooling as a safe, convenient stimulus. As icepacks are already widely applied to temporarily ease local pain, introducing a drug delivery mechanism switched "ON" by cooling could enable long duration, enhanced pain relief triggered by a method with which patients are already familiar. Herein, we demonstrate that cooling-triggered release of NSAIDs can be achieved by leveraging the gel-to-sol transition exhibited by physically cross-linked thermoresponsive polymer hydrogels upon cooling below their lower critical solution temperature (LCST). We demonstrate and characterize cooling-triggered release in simulated body fluid, in cell culture, in explanted tissue, and in a live animal wound model. We show that hydrogels loaded with an NSAID (Celecoxib) can be combined with a nonthermoresponsive membrane material to create implantable devices that demonstrate up to a ∼40× increase in drug release rate upon mild cooling (29 °C) and that support multiple cycles of triggered release. These results demonstrate that cooling-triggered release of therapeutics is a promising concept that could allow patients to use a familiar method (applying an icepack to pain points) to achieve enhanced pain relief.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。